Please Wait
Applying Filters...

List of All Manufacturers & Suppliers of Tazarotene Licensing, EU CTD Dossiers, Marketing Authorizations, Finished Dosage Formulations listed on PharmaCompass.com

Menu
$ API Ref.Price (USD/KG) : 16,511Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 7Allergan Aesthetics

02 1Taro Pharmaceutical Industries

03 2Bausch & Lomb Incorporated

04 2Bausch Health

05 4Chongqing Huapont Pharmaceutical

06 3Cosette Pharma

07 2Farmatek

08 1Fougera Pharmaceuticals Inc.

09 1Mayne Pharma

10 1Midas Care Pharmaceuticals

11 3Padagis

12 2Pierre Fabre

13 2Solaris Pharma

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 1997-06-13

Application Number : 20600

Regulatory Info : RX

Registration Country : USA

Abbvie CB

02

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 1997-06-13

Application Number : 20600

Regulatory Info : RX

Registration Country : USA

Abbvie CB

03

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2000-09-29

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

04

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZORAC

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2000-09-29

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

05

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : AVAGE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2002-09-30

Application Number : 21184

Regulatory Info : RX

Registration Country : USA

Abbvie CB

06

arrow
AAPS 2024
Not Confirmed

Tazarotene

Brand Name : Zorac 0,05%

Dosage Form : GEL

Dosage Strength : 5mg/ml

Packaging : 30X1mg/ml

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie CB

07

arrow
AAPS 2024
Not Confirmed

Tazarotene

Brand Name : Zorac 0,1%

Dosage Form : GEL

Dosage Strength : 1mg/g

Packaging : 30X1mg/g

Approval Date :

Application Number :

Regulatory Info : Originator

Registration Country : South Africa

Abbvie CB

08

arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2017-04-03

Application Number : 208258

Regulatory Info : RX

Registration Country : USA

blank

09

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

HALOBETASOL PROPIONATE; TAZAROTENE

Brand Name : DUOBRII

Dosage Form : LOTION;TOPICAL

Dosage Strength : 0.01%;0.045%

Packaging :

Approval Date : 2019-04-25

Application Number : 209354

Regulatory Info : RX

Registration Country : USA

blank

10

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : ARAZLO

Dosage Form : LOTION;TOPICAL

Dosage Strength : 0.045%

Packaging :

Approval Date : 2019-12-18

Application Number : 211882

Regulatory Info : RX

Registration Country : USA

blank

11

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2017-12-22

Application Number : 208662

Regulatory Info : RX

Registration Country : USA

blank

12

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2022-09-13

Application Number : 214136

Regulatory Info : RX

Registration Country : USA

blank

13

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2022-09-13

Application Number : 215433

Regulatory Info : RX

Registration Country : USA

blank

14

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2019-01-28

Application Number : 211175

Regulatory Info : DISCN

Registration Country : USA

blank

15

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : FABIOR

Dosage Form : AEROSOL, FOAM;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2012-05-11

Application Number : 202428

Regulatory Info : RX

Registration Country : USA

blank

16

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2023-04-25

Application Number : 213079

Regulatory Info : RX

Registration Country : USA

blank

17

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2023-04-25

Application Number : 213079

Regulatory Info : RX

Registration Country : USA

blank

18

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : CREAM;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2024-07-15

Application Number : 217075

Regulatory Info : RX

Registration Country : USA

blank

19

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.05%

Packaging :

Approval Date : 2023-03-20

Application Number : 213644

Regulatory Info : RX

Registration Country : USA

blank

20

AAPS 2024
Not Confirmed
arrow
arrow
AAPS 2024
Not Confirmed

TAZAROTENE

Brand Name : TAZAROTENE

Dosage Form : GEL;TOPICAL

Dosage Strength : 0.1%

Packaging :

Approval Date : 2023-03-20

Application Number : 213644

Regulatory Info : RX

Registration Country : USA

blank